O'Brien Thomas F MD is categorized under Internal Medicine Doctors in Boston, MA and active since 2010.
O'Brien Thomas F MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Thomas O'Brien at the company’s single location by writing to 75 Francis St, Boston, Massachusetts MA 02115 or by phoning (617) 732-6803. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | O'Brien Thomas F MD |
Contact Person: | Thomas O'Brien |
Address: | 75 Francis St, Boston, Massachusetts 02115 |
Phone Number: | (617) 732-6803 |
Website Address: | researchfaculty.brighamandwomens.org |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
O'Brien Thomas F MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Thomas O'Brien for inquiries that concern O'Brien Thomas F MD by calling the company number (617) 732-6803, as your correspondence is most welcome. Additionally, the physical location of the single location of O'Brien Thomas F MD can be found at the coordinates 42.336029,-71.107687 as well as the street address 75 Francis St in Boston, Massachusetts 02115.
For its online presence, you may visit O'Brien Thomas F MD’s website at researchfaculty.brighamandwomens.org and engage with its social media outlets through on Twitter and on Facebook.